吉林大学学报(医学版) ›› 2017, Vol. 43 ›› Issue (06): 1161-1164.doi: 10.13481/j.1671-587x.20170617

• 研究基础 • 上一篇    下一篇

樟脑磺哑嗪对人宫颈癌HeLa细胞凋亡的诱导作用及其机制

徐丽1, 张巍2   

  1. 1. 北华大学附属医院妇产科, 吉林 吉林 132011;
    2. 吉林医药学院生物化学教研室, 吉林 吉林 132013
  • 收稿日期:2017-03-27 出版日期:2017-11-28 发布日期:2017-12-01
  • 通讯作者: 徐丽,副教授(Tel:0432-62166421,E-mail:1064141993@qq.com) E-mail:1064141993@qq.com
  • 作者简介:徐丽(1972-),女,吉林省吉林市人,副教授,医学硕士,主要从事妇产科肿瘤方面的研究。
  • 基金资助:
    吉林省教育厅"十二五"科学技术研究项目资助课题(2015-171)

Induction of oxaziridine on apoptosis of human cervical cancer HeLa cells and its mechanism

XU LI1, ZHANG Wei2   

  1. 1. Department of Gynaecology and Obstetrics, Affiliated Hospital, Beihua University, Jilin 132011, China;
    2. Department of Biochemistry, Jilin Medical University, Jilin 132013, China
  • Received:2017-03-27 Online:2017-11-28 Published:2017-12-01

摘要: 目的:探讨樟脑磺哑嗪对人宫颈癌HeLa细胞凋亡的诱导作用及其机制。方法:人宫颈癌HeLa细胞分为对照组和不浓度樟脑哑嗪组,分别以浓度为0、0.5、1.0、5.0和10.0 μmol·L-1樟脑磺哑嗪处理,24 h后MTT法检测各组HeLa细胞存活率和增殖抑制率。人宫颈癌HeLa细胞分为0、0.5、1.0和5.0 μmol·L-1樟脑磺哑嗪组,12 h后倒置显微镜下观察各组HeLa细胞形态表现,Hoechst 33258染色检测各组HeLa细胞凋亡形态表现,Western blotting法检测HeLa细胞中凋亡相关蛋白Bax和Bcl-2相对表达水平。结果:MTT法检测,与对照组(0 μmol·L-1)比较,0.5,1.0,5.0和10.0 μmol·L-1樟脑磺哑嗪组HeLa细胞存活率降低(P<0.05或P<0.01),增殖抑制率升高(P<0.05或P<0.01);樟脑磺哑嗪对HeLa细胞的半数抑制浓度(IC50)为2.6 μmol·L-1。对照组(0 μmol·L-1樟脑磺哑嗪组)细胞生长状态良好,0.5、1.0和5.0 μmol·L-1樟脑磺哑嗪组HeLa细胞的体积明显缩小,细胞间连接消失;Hoechst 33258染色,樟脑磺哑嗪处理的细胞出现明显的染色增加。Western blotting法检测,与对照组(0 μmol·L-1樟脑磺哑嗪组)比较,0.5、1.0和5.0 μmol·L-1樟脑磺哑嗪组HeLa细胞中Bcl-2蛋白相对表达水平明显降低(P<0.05或P<0.01),Bax蛋白相对表达水平明显升高(P<0.05或P<0.01)。结论:樟脑磺哑嗪可有效抑制体外培养的宫颈癌HeLa细胞的增殖,诱导HeLa细胞凋亡。

关键词: 樟脑磺哑嗪, 宫颈肿瘤, HeLa细胞, 细胞增殖, 细胞凋亡

Abstract: Objective:To explore the induction of oxaziridine on the apoptosis of human cervical cancer HeLa cells and its mechanism. Methods:The human cervical cancer HeLa cells were treated with 0,0.5,1.0,5.0 and 10.0 μmol·L-1 oxaziridine for 24 h and used as control group and different concentrations of experiment groups. The morphology of HeLa cells was observed under inverted microscope; the surival rates and inhibitroy rates of proliferation of the HeLa cells in various groups were measured by MTT assay. The HeLa cells were treated with 0,0.5,1.0 and 5.0 μmol·L-1 oxaziridine for 12 h, and Hoechst 33258 staining was used to detect the apoptotic morphology of the cells; Western blotting method was used to detect the relative expression levels of Bcl-2 and Bax proteins. Results:The MTT assay results showed that the survival rates of the HeLa cells in 0.5,1.0,5.0 and 10.0 μmol·L-1 groups were decreased and the inhibitory rates of proliferation of the HeLa cells were increased(P<0.05 or P<0.01)compared with control group, and the half inhibitory concentration(IC50)was 2.6 μmol·L-1. The cells in control group(0 μmol·L-1 oxaziridine group) were in good condition, and the volumes of the HeLa cells in 0.5, 1.0,5.0 and 10 μmol·L-1 groups were significantly reduced and the intercellular junction also disappeared. The Hoechst 33258 staining results showed the enhanced staining in the cells treated with oxaziridine.The Western blotting results showed that compared with control group(0 μmol·L-1 oxaziridine group), the relative expression levels of Bcl-2 protein in the HeLa cells in 0.5, 1.0 and 5.0 μmol·L-1 oxaziridine groups were significantly decreased(P<0.05 or P<0.01), and the relative expression levels of Bax protein were significantly increased (P<0.05 or P<0.01). Conclusion:Oxaziridine can effectively inhibit the proliferation of HeLa cells in vitro and induce the apoptosis of HeLa cells.

Key words: HeLa cells, cell proliferation, apoptosis, oxaziridine, cervical neoplasms

中图分类号: 

  • R737.33